DALLAS, June 19, 2019 (GLOBE NEWSWIRE) -- via OTC
PR WIRE -- Puration, Inc. (PURA)
(â€PURAâ€) management today emphasized that the $1.5 million contract
to produce a 25 mg CBD beverage for which production initiated
yesterday, represents new revenue on top of the company’s ongoing
sales accounting for over $1 million in annualized revenue.
The $1.5 million contract to produce the private label beverage is
a major step toward PURA’s 2019 target of reaching $4 million in
revenue.
With Kali-Extracts, Inc. (aka Kali, Inc.)
(KALY) (“KALYâ€) bringing their CBD
extraction expertise based on the U.S. Patented Cannabis Extraction
process that they own and operate, PURA has initiated production of
a new beverage infused with 25 mg of hemp derived CBD. Most
CBD infused beverages contain only 5 mg of CBD with a few
containing 10 mg. Beverages with 25 mg of CBD are hard to
find. PURA has been producing a CBD infused sports water
infused with 10 mg of CBD since 2017. PURA markets and sells
the CBD sports water under the brand name EVERx and achieved over
$1 million in sales in 2018. PURA has the sole license of
KALY’s U.S. Patented Cannabis Extraction Process. PURA and
KALY have partnered on the development of a CBD extraction that can
support a clear and sustained suspension at the 25 mg level.
As of today, the production of a 25 mg CBD beverage has been
initiated for production at a Texas facility. Texas Governor
Greg Abbott signed a new law last week legalizing hemp and
hemp-derived products. The 25 mg CBD beverage is being
produced in fulfillment of a $1.5 million contract where PURA is
producing the beverage under a private label for a third
party. PURA has in turn engaged KALY for its extract
expertise.
PURA Speculative Buy Recommendation and $0.25 PPS Target
w/Potential to $0.35
Goldman Small Cap Research has released a new
research report recommending PURA as a Speculative BUY with a
$0.25 PPS Target. Goldman Small Cap Research further
reports that the shares of PURA “have the potential to reach the
$0.35 mark.†The report highlights PURA’s growing EVERx CBD
Sports Water sales and the coming introduction of new beverages as
well as the potential for the company to exceed its 2019 sales
targets through the pending doubling of its production capacity and
through planned acquisitions. The report further details
recent updates intended to accelerate the issue of Nouveau
(NOUV) stock to PURA shareholders in a
dividend distribution. Notably, the report points to the
capacity and quality improvements enabled by the addition of a new
team member with exceptional beverage industry professional
experience.
For more information on Puration, visit http://www.purationinc.com
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the
meaning of the Securities Litigation Reform Act. The statements
reflect the Company's current views with respect to future events
that involve risks and uncertainties. Among others, these risks
include the expectation that any of the companies mentioned herein
will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the
companies' liquidity position, the companies' ability to obtain new
contracts, the emergence of competitors with greater financial
resources and the impact of competitive pricing. In the light of
these uncertainties, the forward-looking events referred to in this
release might not occur. These statements have not been evaluated
by the Food and Drug Administration. These products are not
intended to diagnose, treat, cure, or prevent any
disease.
Contact:
Puration, Inc.
Brian Shibley
[email protected]
(800) 861-1350